Nosadini et al., 1989 - Google Patents
Kidney hemodynamics after ketone body and amino acid infusion in normal and IDDM subjectsNosadini et al., 1989
- Document ID
- 14771059106132228434
- Author
- Nosadini R
- Trevisan R
- Fioretto P
- Semplicini A
- Samà B
- Velussi M
- Luigi Da Campo G
- Avogaro A
- Vizzaccaro A
- Donadon V
- Mongillo S
- Doria A
- Publication year
- Publication venue
- Diabetes
External Links
Snippet
Little information is available on the hemodynamic response (renal reserve) of the diabetic kidney during an acute amino acid infusion, which has been shown to increase glomerular filtration rate (GFR) in normal humans. We recently found that the infusion of ketone bodies …
- 238000001802 infusion 0 title abstract description 92
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Irazabal et al. | Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease | |
Bergeron et al. | Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats | |
Heimbürger et al. | Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. | |
COTTIER et al. | Effect of an intravenous sodium chloride load on renal hemodynamics and electrolyte excretion in essential hypertension | |
DeFronzo et al. | Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. | |
Arem et al. | Reduced tissue thyroid hormone levels in fatal illness | |
Luzi et al. | Leucine metabolism in IDDM: role of insulin and substrate availability | |
Bie et al. | Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs | |
Gansevoort et al. | Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition | |
Nosadini et al. | Kidney hemodynamics after ketone body and amino acid infusion in normal and IDDM subjects | |
Duarte et al. | Assessment of renal function—glomerular and tubular | |
Skøtt et al. | Effect of insulin on renal sodium handling in hyperinsulinaemic type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance | |
Shulman et al. | Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog. | |
Natali et al. | Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man | |
FERRARI et al. | Dysregulation of atrial natriuretic factor in hypertension-prone man | |
Jamiołkowska-Sztabkowska et al. | C-peptide and residual β-cell function in pediatric diabetes–state of the art | |
Wong et al. | Glomerular hyperfiltration in patients with well-compensated alcoholic cirrhosis | |
Shmueli et al. | High Insulin–Like Growth Factor Binding Protein 1 Levels in Cirrhosis: Link With Insulin Resistance | |
Heslin et al. | Effect of systemic hyperinsulinemia in cancer patients | |
Lim et al. | The effect of interdialytic interval on protein metabolism: Evidence suggesting dialysis-induced catabolism | |
Niwa et al. | Uremic toxicity: Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure | |
Wong et al. | The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis | |
Luik et al. | Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus | |
Trevisan et al. | Ketone bodies increase glomerular filtration rate in normal man and in patients with type 1 (insulin-dependent) diabetes mellitus | |
Ferrannini et al. | Insulin enhances renal glucose excretion: relation to insulin sensitivity and sodium-glucose cotransport |